Heze: Seventh batch of national drug collection in a medicine

On July 13, the seventh batch of national drug centralized procurement results were announced. Media reporters learned from the Heze High -tech Zone that the pharmaceutical injection reported by Shandong Runze Pharmaceutical Co., Ltd., a subsidiary of Ruiying Group, was selected as the bid.

This concentrated procurement is the seventh batch of drugs in the national organization. During the procurement cycle, the medical institution will give priority to the use of this drug concentrated procurement of drugs and ensure that the agreed procurement volume is completed. This procurement is included in 61 drugs, including common diseases such as hypertension, diabetes, anti -infection, and digestive tract diseases, as well as major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer.

Sodium custard sodium in injection is anti -infected drugs, and is suitable for the treatment of linter, pneumonia, pneumonia, pneumonia, colonbaccinis, colorectal, Cleper, and transformelona , Acute bronchitis, pneumonia, secondary respiratory diseases such as secondary infection.

Runze Pharmaceutical is an important pharmaceutical project in Heze High -tech Zone in the biopharmaceutical industry. It is also an important part of building the entire industry chain of the biomedical industry. As the main position of the city's biopharmaceutical industry, there are more than 50 biomedical companies in Heze High -tech Zone. The products cover more than a thousand varieties of traditional Chinese medicine, western medicine, and pharmaceutical equipment, forming a complete industrial chain.

Heze Newspaper All Media Reporter Wu Yan

- END -